{
  "pmcid": "12459523",
  "sha256": "a1d23067c7863cef43a933e1b847932fda67fd389b6fc5844575c44b69a12fd5",
  "timestamp_utc": "2025-11-09T23:39:33.468611+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.141227272727274,
    "reading_ease": 39.67584090909094,
    "word_count": 275
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of LFCN Block Addition to PENG Block in Hip Fracture Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "60 patients aged 18-75 were randomised into three groups"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at Zonguldak Bülent Ecevit University Hospital, Türkiye, from October 2022 to January 2024, 60 patients aged 18-75 were randomised"
      },
      "Intervention": {
        "score": 2,
        "evidence": "The PENG group received 20 mL of 0.25% bupivacaine, while the PENG + LFCN group received an additional 5 mL LFCN block"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed the impact of adding a lateral femoral cutaneous nerve (LFCN) block to a pericapsular nerve group (PENG) block on postoperative opioid consumption and pain scores"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was postoperative opioid consumption within 24 hours"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-assisted with allocation concealment via sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "60 patients aged 18-75 were randomised into three groups"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "60 patients were analysed (20 per group) using a per-protocol approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Postoperative opioid consumption was significantly lower in the PENG (8.10 ± 6.72 mg) and PENG + LFCN (8.40 ± 4.38 mg) groups compared to CONTROL (15.30 ± 5.59 mg, P < 0.001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT06226675"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 22,
    "max_score": 25
  }
}